drugset

drugset / Trial / NCT03642210

Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

NCT03642210 ↗

Phase 3 Completed 105 enrolled Medicines360

NaSingle-groupOpen-labelTreatment

Summary

To assess the efficacy of a levonorgestrel 52 mg intrauterine system as a treatment for heavy menstrual bleeding.

Timeline

Start: 2019-01-17
Primary completion: 2021-10-12
Completion: 2021-10-12

Publications

Creinin MD, Barnhart KT, Gawron LM, Eisenberg D, Mabey RG Jr, Jensen JT. Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device. Obstet Gynecol. 2023 May 1;141(5):971-978. doi: 10.1097/AOG.0000000000005137. Epub 2023 Apr 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levonorgestrel	Small molecule	52 mg	Other

Indications